- Home
- CTSO vs MGN Comparison
CTSO vs MGN Comparison
Compare CTSO & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- MGN
- Stock Information
- Founded
- CTSO 1997
- MGN 2020
- Country
- CTSO United States
- MGN Malaysia
- Employees
- CTSO N/A
- MGN N/A
- Industry
- CTSO Medical/Dental Instruments
- MGN
- Sector
- CTSO Health Care
- MGN
- Exchange
- CTSO Nasdaq
- MGN Nasdaq
- Market Cap
- CTSO 45.3M
- MGN 43.0M
- IPO Year
- CTSO N/A
- MGN 2025
- Fundamental
- Price
- CTSO $0.64
- MGN $1.68
- Analyst Decision
- CTSO Buy
- MGN
- Analyst Count
- CTSO 2
- MGN 0
- Target Price
- CTSO $5.38
- MGN N/A
- AVG Volume (30 Days)
- CTSO 106.4K
- MGN 638.1K
- Earning Date
- CTSO 11-13-2025
- MGN 12-02-2025
- Dividend Yield
- CTSO N/A
- MGN N/A
- EPS Growth
- CTSO N/A
- MGN N/A
- EPS
- CTSO N/A
- MGN 0.07
- Revenue
- CTSO $36,979,520.00
- MGN $13,484,571.00
- Revenue This Year
- CTSO $11.93
- MGN N/A
- Revenue Next Year
- CTSO $21.22
- MGN N/A
- P/E Ratio
- CTSO N/A
- MGN $20.33
- Revenue Growth
- CTSO 20.75
- MGN N/A
- 52 Week Low
- CTSO $0.60
- MGN $1.30
- 52 Week High
- CTSO $1.61
- MGN $8.63
- Technical
- Relative Strength Index (RSI)
- CTSO 24.35
- MGN N/A
- Support Level
- CTSO $0.60
- MGN N/A
- Resistance Level
- CTSO $0.70
- MGN N/A
- Average True Range (ATR)
- CTSO 0.06
- MGN 0.00
- MACD
- CTSO -0.01
- MGN 0.00
- Stochastic Oscillator
- CTSO 5.54
- MGN 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.